ESI-GROUP
8.6.2021 14:02:09 CEST | Business Wire | Press release
Regulatory News:
ESI Group (Paris:ESI), a global player in virtual prototyping for industries, participates in the successful development phase of the Nivus made by Volkswagen do Brazil: 100% digitally and virtually – a world premiere. The process began before the pandemic and was completed during the COVID-19 period, applying all the sanitary measures in place. Thanks to Virtual Prototyping/Digital Development (a change in product development), time was shortened in about 10 months and saved a few million euros in prototype production costs: Would it be a shift in the industry?
Making the right decision, quickly and 100% digitally
Usually, when a new vehicle is developed, time and physical prototypes are required both during the design and assembly preparation phases. In the case of the Nivus, launched in a live broadcast by Volkswagen do Brazil in June 2020 to around 60 countries, the whole conception of the vehicle was made 100% virtually.
The state-of-the-art solution provided by ESI Group, based on its software IC.IDO
was one of the tools used to design reviews and engineering decisions in different departments (product development, operations, quality, etc). This allowed Volkswagen to make informed decisions regarding the car’s conception. It provided the automotive company with the opportunity to save time (shortened the car’s development in about 10 months) and investment (for example, only in the Virtual Prototype Laboratory there was a 65% reduction of costs compared to previous projects).
Virtual reality also conserves tons of paper, in which specifications for each part of a car were previously detailed.
Long before Nivus physically existed, the vehicle was already available digitally in the engineering computers. Considering that building a physical prototype takes 19 weeks, in which only a single vehicle variant is possible. For this vehicle, nine virtual variants were produced, in much less time, which made it possible to anticipate more efficient assembly procedures, reducing the number of processes in the simulations and avoiding errors, since all parts were previously tested with digital tools.
"We designed 100% of the Nivus with digital processes using, among others, ESI’s technology without the need to assemble a single physical prototype. In addition, with the drastic reduction of the development time, this solution helps us to integrate all our different teams, from various department (design, engineering, marketing, production, etc) in the same decision-making process. It was a more efficient but also more collaborative process. " explains Francisvaldo Gomes Aires, Prototyping Development Manager at Volkswagen do Brazil.
Virtual reality: A huge benefit during COVID-19
ESI demonstrated that even when the design phase is impacted, in this case by COVID-19, it is possible to continue with the project, since it is no longer a question of relying solely on physical reality. This opens up the possibility of experiencing the future with digitalization and technology for the project benefit.
“It’s a shift in the industrial production. For the first time, all phases of a car release, before the effective production, has been fully made virtually making the production feasible during Covid-19 time. While allowing Volkswagen to take all its design and manufacturing decisions virtually, we helped them produce faster, cheaper and in a more sustainable way. This was possible due to a strong support of our local Brazilian team and a mutual collaboration between ESI Brazil and Volkswagen do Brazil. We all feel proud to be part of this world-premiere alongside with Volkswagen and its partners.” declares Andreas Renner, Volkswagen Global Account Manager – ESI Group.
About ESI Group
Founded in 1973, ESI Group is a leading innovator in Virtual Prototyping solutions and a global enabler of industrial transformation. Thanks to the company’s unique know-how in the physics of materials, it has developed and refined, over the last 45 years, advanced simulation capabilities. Having identified gaps in the traditional approach to Product Lifecycle Management (PLM), ESI has introduced a holistic methodology centered on industrial productivity and product performance throughout its entire lifecycle, i.e. Product Performance Lifecycle™, from engineering to manufacturing and in operation. Present in more than 20 countries, and in major industrial sectors, ESI employs 1200 high level specialists around the world and reported 2020 sales of €132.6 million. ESI is headquartered in France and is listed on compartment B of Euronext Paris.
For further information, go to www.esi-group.com .
Follow ESI
http://www.esi-group.com/linkedin
http://www.esi-group.com/facebook
http://www.esi-group.com/twitter
http://www.esi-group.com/youtube
View source version on businesswire.com: https://www.businesswire.com/news/home/20210608005672/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Murata Launches Ultra-Low Power AMR Sensors to Boost Battery Life in Healthcare and Wearables Devices27.4.2026 04:00:00 CEST | Press release
Murata Manufacturing Co., Ltd. (TOKYO: 6981) (ISIN: JP3914400001) has commenced mass production of its MRMS166R and MRMS168R anisotropic magnetoresistance (AMR) sensors for healthcare, wearable, and IoT devices. The MRMS166R is the first AMR sensor to combine an average current consumption of 20 nA with operation from a 1.2 V supply, enabling extended battery life in coin cell-powered systems. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260413296947/en/ [Murata Manufacturing Co., Ltd.] AMR sensor The devices are solid-state magnetic sensors used for switching applications. They detect the presence or absence of a magnetic field and generate an output signal that system logic uses to control functions such as transitions between active and sleep modes. This enables contactless switching without mechanical components, improving reliability, and supporting sealed, miniaturized designs. Automatic switching between active and
Sun Pharma signs Definitive Agreement to Acquire Organon27.4.2026 01:51:00 CEST | Press release
Organon stockholders to receive US$ 14.00 per share in cashThe deal values Organon at EV of US$ 11.75 billionCombined Business leverages complementary portfolios and global scale for sustained long‑term value creation Sun Pharmaceutical Industries Limited(Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) (together with its subsidiaries and/or associated companies, “Sun Pharma”) and Organon & Co. (NYSE: OGN) (“Organon”) today announced that they have entered into a definitive agreement under which Sun Pharma will acquire all outstanding shares of Organon for US$ 14.00 per share in an all‑cash transaction with an enterprise valuation of US$ 11.75 billion. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260426881370/en/ Organon is a global healthcare company formed through a spinoff from Merck, known as MSD outside of the United States and Canada, in 2021. Organon has a legacy of deep trust and strong brand equit
Andersen Global udvider sin tilstedeværelse i Afrika med lanceringen af medlemsfirma i Cameroun26.4.2026 20:56:00 CEST | Pressemeddelelse
Andersen Global træder ind på det camerounske marked, idet Phoenix Advisory bliver medlemsfirma og overgår til Andersen-brandet. Andersen in Cameroun er et specialiseret rådgivningsfirma, der leverer strategiske, erhvervsmæssige, finansielle og operationelle rådgivningsydelser til organisationer i forskellige vækstfaser. Firmaet er grundlagt af fagfolk med erfaring fra store internationale organisationer og kombinerer et stærkt lokalt og centralafrikansk funderet kendskab til forretningsmæssige, juridiske og skattemæssige regler med en skræddersyet tilgang, der har til formål at skabe konkrete og målbare resultater for klienterne. "Overgangen til Andersen-brandet afspejler vores engagement i at vokse sammen med vores kunder og imødekomme stadig mere komplekse behov," udtalte administrerende partner Albert Désiré Zang. "Vi tror på, at langsigtet succes skabes gennem tillid, kvalitet og vedvarende support. At blive et medlemsfirma styrker vores evne til at levere gennemtænkte, bæredygtig
PMCOrganometallix Announces Price Increase on All Products24.4.2026 22:55:00 CEST | Press release
Due to significant changes in market conditions, PMC Organometallix, Inc. announces that effective May 1, 2026, or as contracts permit, prices across all product lines globally will increase by 10-25%. This adjustment is driven by sustained cost pressures from key inputs including rising raw material costs and escalating freight and logistics expenses. While the company has been absorbing these increases, the current economic environment brought on by the geopolitical crisis of the Iran conflict requires this adjustment to continue providing the high-quality, consistent materials and supply reliability that customers expect. PMC Organometallix will implement these changes in a transparent, collaborative manner and values your partnership while navigating these economic challenges. Customers with questions or to discuss a specific situation should contact their account representative. About PMC Group PMC Group is a growth-oriented, diversified, global chemicals and plastics company deli
Frankfurt Higher Regional Court upholds BESREMi® arbitral award in favor of AOP Health24.4.2026 18:52:00 CEST | Press release
Today, the Higher Regional Court of Frankfurt upheld the February 20251 partial final ICC arbitral award in favor of AOP Orphan Pharmaceuticals GmbH (“AOP Health”) in its dispute with PharmaEssentia Corp. (“PharmaEssentia”). The ruling confirms the award which found the Taiwanese company to be liable for certain damages. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260424005227/en/ Portrait Dr. Rudolf Widmann, Founder AOP Health Credit: AOP Health/Daniel Ospelt Dr. Rudolf Widmann, one of the two founders of AOP Health, explains: “We very much welcome the Frankfurt Higher Regional Court’s decision that confirms our position. In the interest of our patients, we are dedicated to maintaining stable and sustainable access to BESREMi® and to responsibly navigating future challenges.” The Product in Dispute The conflict centers around BESREMi® (ropeginterferon alfa-2b), a product launched in 2019 and developed by AOP Health into
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
